Download our free report, “A rising future: The dynamics of the growing respiratory drug market”
The respiratory market accounts for almost 25% of drug spending globally. Yet only a small proportion of the total research and development budget is spent in this area, thus reducing the chances of novel drug targets being identified.
The respiratory drug market is perceived as rapidly growing due to the increasing number of patients affected by respiratory-related pathologies.
Some respiratory facts
- 3 million deaths annually
- €380b: total cost including hospitalization
- 235 million patients globally
Our report, "A rising future: The dynamics of the growing respiratory drug market" discusses the currently available treatments for respiratory diseases, our main challenges, and finally what lies ahead.
Download your free copy today.